INNATE PHARMA SA-SPONS ADR (IPHA) Stock Earnings Estimates

NASDAQ:IPHA • US45781K2042

1.65 USD
-0.07 (-3.79%)
Last: Mar 2, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IPHA revenue by date.IPHA revenue by date.
49.58M
309.35%		51.901M
4.68%		12.622M
-75.68%		25.818M
104.55%		25.319M
-1.93%		15.809M
-37.56%		64.861M
310.28%		192.15M
196.25%		169.64M
-11.71%		219.94M
29.65%		258.83M
17.68%		440.9M
70.34%
EBITDA
YoY % growth
IPHA ebitda by date.IPHA ebitda by date.
28.98M
167.04%		-7.578M
-126.15%		-49.581M
-554.28%		27.27M
155.00%		144.43M
429.63%		192.91M
33.57%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IPHA ebit by date.IPHA ebit by date.
-16.425M
65.66%		-12.669M
22.87%		-51.575M
-307.10%		-15.288M
70.36%		34.614M
326.41%		-61.384M
-277.34%		-65.419M
-6.57%		41.243M
163.04%		64.201M
55.67%		103.81M
61.70%		132.25M
27.40%		N/A
Operating Margin
IPHA operating margin by date.IPHA operating margin by date.
-33.13%-24.41%-408.61%-59.21%136.71%-388.28%-100.86%21.46%37.85%47.20%51.10%N/A
EPS
YoY % growth
IPHA eps by date.IPHA eps by date.
N/A
72.93%		N/A
-169.82%		N/A
23.22%		-0.52
-35.80%		-0.46
10.00%		-0.64
-38.38%		N/AN/AN/AN/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.11-0.11-0.11
-9.09%		-0.07
72.00%		-0.12
-8.33%		-0.09
16.67%		-0.12
-8.33%		-0.12
-85.71%		-0.08
30.77%		-0.12
-30.00%
Revenue
Q2Q % growth		1.98M2.172M
-49.83%		2.222M
-54.35%		7.817M
367.80%		2.293M
15.81%		2.404M
10.68%		2.353M
5.90%		2.788M
-64.33%		9.878M
330.79%		6.989M
190.72%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-12.857M-12.665M
49.86%		-13.019M
-34.83%		-8.211M
67.71%		-13.645M
-6.13%		-16.17M
-27.67%		-19.766M
-51.82%		-19.443M
-136.78%		-14.685M
-7.62%		-19.917M
-23.17%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth		 -0.59
-684.99%		%
IPHA Yearly EPS VS EstimatesIPHA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth		 1.671M
-79.85%		4.909M-3.238M-65.96%
Q4 2024
Q2Q % growth		 4.329M
-73.85%		%
Q2 2024
Q2Q % growth		 8.293M
-76.54%		%
Q4 2023
Q2Q % growth		 16.557M
99.27%		%
Q2 2023
Q2Q % growth		 35.344M
-14.36%		%
Q4 2022
Q2Q % growth		 8.309M
118.20%		%
Q2 2022
Q2Q % growth		 41.271M
397.00%		%
Q4 2021
Q2Q % growth		 3.808M
-85.53%		%
Q2 2021
Q2Q % growth		 8.304M
-72.17%		%
Q4 2020
Q2Q % growth		 26.31M 27.379M-1.069M-3.90%
IPHA Yearly Revenue VS EstimatesIPHA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.01% 1.64% 0.01% -0.55%
Revenue0% 0% 4.93% 4.93%